Advancing the Vaccine Law Dialogue

Pre-conference: September 13 Washington, D.C.

Proceedings

On behalf of the board of directors of the National Vaccine Law Association, we thank you for joining us and sharing your knowledge and expertise with our audience. We are pleased to announce that we will once again be publishing our conference proceedings, which will give speakers and others in the field the opportunity to add to the literature and discuss contemporary issues in vaccine law and policy.

Our proceedings are being developed as a peer reviewed publication and are meant to provide a space of continuous engagement, sharing research, and expanding on reflections during and after the conference. We first invite paper submissions from conference speakers, but will consider all submissions.  

Submissions should be scholarly in nature, contribute to new legal analysis, scientific knowledge, or public health practice, and we encourage writers to include a call-out box, paragraph, or section focused on health equity considerations. Submissions will be held to similar peer-review standards as submissions to peer-reviewed journals.

Conference speakers interested in submitting a full manuscript should first send a brief abstract for initial review and comment. Abstracts should contain a proposed title, a description of not more than 400–500-words, including potential health equity considerations, and the names and affiliations of the authors. No tables or figures should be included in the abstract. Abstracts should be submitted by July 31, 2024 to Proceedings@vaccinelawconference.org.

The editors will review all abstracts and authors will receive notice of a request to submit a full manuscript by September 12, 2024. Submitted final manuscripts should follow the “Bluebook” citation model and will be due by January 31, 2025.

We are reserving spaces for papers which speak directly to the topics featured at the National Vaccine Law Conference. However, if you have relevant work related to vaccine law or policy in the 21st century, please consider submitting that as well. 

Open access: Some potential authors have raised the question of open access. We are pleased to affirm our commitment to open access for scholarly works exploring and expanding the field of Vaccine Law. Authors contributing articles to our 2023 conference proceedings may make their work available through the open access platform of their choosing, with appropriate attribution.

Some topics of interest are:

  • Safety and Licensure Strategy 
  • Legal Structure of Funding and Distribution 
  • International Vaccine Law 
  • Vaccine Misinformation, Hesitancy, & Refusal 
  • Equity Throughout the Vaccine Life Cycle 
  • Medicaid Policy Analysis 
  • COVID-19 Vaccinations and the Americans with Disabilities Act 
  • Vaccine Intellectual Property Law 
  • Legal Issues with Vaccines for Sexually Transmitted Diseases
  • Vaccine Injury Compensation 
  • Vaccine Mandates: Religious Exemptions & Faith Communities 
  • Immunization Information Systems (IIS) Policy Legislation 
  • Measles and COVID-19 Vaccine Hesitancy Impacts 

Proceedings from our 2022 conference, for comparison, are available from the American Bar Association, here.

Please email our Corresponding Editor, Brian Dean Abramson at briandeanabramson@gmail.com with any questions. 

 

Please also let us know if you are interested in serving as an editor and/or providing peer review of one or more articles submitted by others. Thank you again for your commitment to this work, and your dedication to keeping our communities safe and healthy